Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global burden of lung cancer: current status and future trends
Amanda Leiter, Rajwanth Veluswamy, Juan P. Wisnivesky
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 624-639
Closed Access | Times Cited: 551

Showing 26-50 of 551 citing articles:

Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision
Nadia Μ. Hamdy, Mohamed Bakr Zaki, Nourhan M. Abdelmaksoud, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Global and China trends and forecasts of disease burden for female lung Cancer from 1990 to 2021: a study based on the global burden of disease 2021 database
B. Li, Yuyan Wu, Yanhong Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access | Times Cited: 1
Deep learning paradigms in lung cancer diagnosis: A methodological review, open challenges, and future directions
Aryan Nikul Patel, Kathiravan Srinivasan
Physica Medica (2025) Vol. 131, pp. 104914-104914
Closed Access | Times Cited: 1
Dual-Locked Fluorescence Probe for Monitoring the Dynamic Transition of Pulmonary Macrophages
Yuxuan Hu, Jing Liu, Mengke Xu, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Global, regional, and national burden and trends of early‐onset tracheal, bronchus, and lung cancer from 1990 to 2019
Jun Ma, Ying‐da Song, Xiaoming Bai
Thoracic Cancer (2024) Vol. 15, Iss. 8, pp. 601-613
Open Access | Times Cited: 7
Phytochemical Screening, In Silico Molecular Docking, ADME Properties, and In Vitro Antioxidant, Anticancer, and Antidiabetic Activity of Marine Halophyte Suaeda maritima (L.) Dumort
Sampath Manojkumar, Murugesan Thandeeswaran, Sathiya Kamatchi Thangavel, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 11200-11216
Open Access | Times Cited: 7
Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 7
Target proteins-regulated DNA nanomachine-electroactive substance complexes enable separation-free electrochemical detection of clinical exosome
Xianghu Zeng, Chengyong Wu, Ying Xiong, et al.
Biosensors and Bioelectronics (2024) Vol. 256, pp. 116273-116273
Closed Access | Times Cited: 7
An explainable transfer learning framework for multi-classification of lung diseases in chest X-rays
Aryan Nikul Patel, Ramalingam Murugan, Gautam Srivastava, et al.
Alexandria Engineering Journal (2024) Vol. 98, pp. 328-343
Open Access | Times Cited: 7
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial
Dawei Chen, Bing Zou, Butuo Li, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102795-102795
Closed Access | Times Cited: 7
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma
Shengqiang Mao, Yilong Wang, Ningning Chao, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1697-1713
Closed Access | Times Cited: 6
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
Javier Torres-Jiménez, Javier Baena Espinar, Helena Bote de Cabo, et al.
Drugs (2024) Vol. 84, Iss. 5, pp. 527-548
Closed Access | Times Cited: 6
Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer
Ming Jiang, Xiaoling Su, Xuwei Zhong, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139403-139403
Closed Access | Times Cited: 6
PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway
Na Li, Ran Zuo, Yuchao He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 6
Screening Low-Risk Individuals for Lung Cancer: The Need May Be Present, but the Evidence of Benefit Is Not
Gerard A. Silvestri, Robert P. Young, Nichole T. Tanner, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1155-1163
Closed Access | Times Cited: 6
Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy
Rajkumar Prabhakaran, Rajkumar Thamarai, Sivabalan Sivasamy, et al.
Epigenetics & Chromatin (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Yujing Guan, Wei Zhang, Yuling Mao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
Zaid Sirhan, Rawan Alojair, Anita Thyagarajan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2090-2090
Open Access | Times Cited: 13
Acetyltransferase P300 Regulates Glucose Metabolic Reprogramming through Catalyzing Succinylation in Lung Cancer
Qingzhi Ma, Qingmei Zeng, Kun Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1057-1057
Open Access | Times Cited: 5
Advancing accuracy in breath testing for lung cancer: strategies for improving diagnostic precision in imbalanced data
Ke-Cheng Chen, Shuenn‐Wen Kuo, Ruei‐Hao Shie, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Green synthesis of CuO nanoparticle using Cyperus rotundus and evaluation of their anticancer potentials against lung cancer cells invitro
Kavita Raj, S. Sujatha, Kanagaraj Muthu-Pandian Chanthini
Biocatalysis and Agricultural Biotechnology (2024) Vol. 57, pp. 103119-103119
Closed Access | Times Cited: 5
Beta hydroxybutyrate induces lung cancer cell death, mitochondrial impairment and oxidative stress in a long term glucose-restricted condition
Farzad Izak Shirian, Milad Karimi, Maryam Alipour, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects
Mohammad Ebrahimnezhad, Amir Valizadeh, Maryam Majidinia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116833-116833
Open Access | Times Cited: 5
Biosensor for the early diagnosis of lung cancer: A DFT study on the applicability of metal-doped graphene structures
Şeyma Korucu, Ahmet Köse, Mehmet Ferdi Fellah
Sensors and Actuators A Physical (2024) Vol. 376, pp. 115637-115637
Closed Access | Times Cited: 5
Explainable Artificial Intelligence in Medical Imaging: A Case Study on Enhancing Lung Cancer Detection through CT Images
Teuku Rizky Noviandy, Aga Maulana, Teuku Zulfikar, et al.
Indonesian Journal of Case Reports (2024) Vol. 2, Iss. 1, pp. 6-14
Closed Access | Times Cited: 5

Scroll to top